Phase 1 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have advanced cancer where the tumour cells carry a protein called Mesothelin.
- People who are expected to live for more than 12 weeks.
- People whose heart, lungs, liver, kidneys, and blood are all functioning well enough to meet the trial's requirements.
- People whose own immune cells (T cells) have been successfully modified in the lab to meet specific activity levels required by the trial (confirm with trial site for full technical details).
- People who have read, understood, and signed the informed consent form, or whose legal guardian has done so on their behalf.
Who may not be able to join:
- People who have previously received gene therapy of any kind.
- People with a serious viral infection, such as hepatitis B, hepatitis C, or HIV.
- People who have a known positive HIV diagnosis.
- People who currently have an active infection caused by bacteria, viruses, fungi, or similar.
- People who are pregnant or currently breastfeeding.
- People who are taking systemic steroid medications at or above a certain daily dose (confirm the exact dose threshold with the trial site).
- People with other serious medical conditions that the trial investigators consider unsuitable for participation.
- People with any other circumstances that the trial investigators consider unsuitable (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University
Phone: 0086-020-39195965
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Patients with Dose Limiting Toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.